RedShift BioAnalytics, Inc.

131 Middlesex Turnpike
MA 01803 Burlington
USA

Contact

About RedShift BioAnalytics

RedShiftBio is a forward-thinking technology company platform for reliable and accurate detection of pivotal changes in molecular structure that affect the critical quality attributes governing the safety, efficacy, and stability of biomolecules and their raw materials. The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS), that provides in-depth structural information in a single automated analysis. RedShiftBio is headquartered out of Burlington, Massachusetts.

Product portfolio of RedShift BioAnalytics

Product portfolio

Show all

White papers by RedShift BioAnalytics

White papers

2 White paper

Measurement of secondary structure directly in formulation without interference from excipients

Learn how MMS offers biotherapeutics formulators the advantage over traditional IR tools to directly measure buffer-induced changes in proteins.

Monoclonal Antibody Analysis by Microfluidic Modulation Spectroscopy in a Complex Formulation Buffer

MMS is a powerful infrared spectroscopy tool for protein structural analysis, providing significant improvements compared to conventional techniques.

RedShift BioAnalytics, Inc.

About RedShift BioAnalytics

Product portfolio of RedShift BioAnalytics

Product portfolio

BMG LABTECH GmbH

Tosoh Bioscience GmbH

White papers by RedShift BioAnalytics

White papers

Measurement of secondary structure directly in formulation without interference from excipients

Measurement of secondary structure directly in formulation without interference from excipients

Monoclonal Antibody Analysis by Microfluidic Modulation Spectroscopy in a Complex Formulation Buffer

Monoclonal Antibody Analysis by Microfluidic Modulation Spectroscopy in a Complex Formulation Buffer

Here you will find RedShift BioAnalytics, Inc.